Bank of New York Mellon
TGAN

Bank of New York Mellon’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bank of New York Mellon’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-79,273
Closed -$389K – 4311
2024
Q1 		$389K Sell
79,273
-7,202
-8% -$34.2K ﹤0.01% 3667
2023
Q4 		$316K Buy
86,475
+854
+1% +$2.34K ﹤0.01% 3776
2023
Q3 		$190K Hold
85,621
– – ﹤0.01% 3971
2023
Q2 		$291K Buy
85,621
+14,189
+20% +$51.2K ﹤0.01% 3842
2023
Q1 		$285K Buy
71,432
+139
+0.2% +$612 ﹤0.01% 3769
2022
Q4 		$388K Buy
71,293
+11,371
+19% +$66.9K ﹤0.01% 3679
2022
Q3 		$301K Buy
59,922
+10,217
+21% +$50.3K ﹤0.01% 3834
2022
Q2 		$189K Buy
+49,705
New +$317K ﹤0.01% 4079

Bank of New York Mellon's TGAN Position: Q2 2024 in Review

Bank of New York Mellon sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 79,273 shares — an estimated $389K sold.

Bank of New York Mellon first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $389K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

  • Bank of New York Mellon reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 79,273 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $389K.
  • Bank of New York Mellon first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Bank of New York Mellon's Transphorm, Inc. Common Stock position peaked at $389K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.